HEADER RNA BINDING PROTEIN 26-JUN-01 1JGN TITLE SOLUTION STRUCTURE OF THE C-TERMINAL PABC DOMAIN OF HUMAN POLY(A)- TITLE 2 BINDING PROTEIN IN COMPLEX WITH THE PEPTIDE FROM PAIP2 COMPND MOL_ID: 1; COMPND 2 MOLECULE: POLYADENYLATE-BINDING PROTEIN 1; COMPND 3 CHAIN: A; COMPND 4 FRAGMENT: C-TERMINAL DOMAIN; COMPND 5 SYNONYM: PABP1; COMPND 6 ENGINEERED: YES; COMPND 7 MOL_ID: 2; COMPND 8 MOLECULE: POLYADENYLATE-BINDING PROTEIN-INTERACTING PROTEIN 2; COMPND 9 CHAIN: B; COMPND 10 FRAGMENT: C-TERMINAL 22 RESIDUES; COMPND 11 SYNONYM: PAIP2; COMPND 12 ENGINEERED: YES SOURCE MOL_ID: 1; SOURCE 2 ORGANISM_SCIENTIFIC: HOMO SAPIENS; SOURCE 3 ORGANISM_COMMON: HUMAN; SOURCE 4 ORGANISM_TAXID: 9606; SOURCE 5 GENE: PABPC1; SOURCE 6 EXPRESSION_SYSTEM: ESCHERICHIA COLI; SOURCE 7 EXPRESSION_SYSTEM_TAXID: 562; SOURCE 8 EXPRESSION_SYSTEM_STRAIN: BL21 GOLD; SOURCE 9 EXPRESSION_SYSTEM_VECTOR_TYPE: PLASMID; SOURCE 10 EXPRESSION_SYSTEM_PLASMID: PGEX-6P-1; SOURCE 11 MOL_ID: 2; SOURCE 12 ORGANISM_SCIENTIFIC: HOMO SAPIENS; SOURCE 13 ORGANISM_COMMON: HUMAN; SOURCE 14 ORGANISM_TAXID: 9606; SOURCE 15 EXPRESSION_SYSTEM: ESCHERICHIA COLI; SOURCE 16 EXPRESSION_SYSTEM_TAXID: 562; SOURCE 17 EXPRESSION_SYSTEM_STRAIN: BL21 GOLD; SOURCE 18 EXPRESSION_SYSTEM_VECTOR_TYPE: PLASMID; SOURCE 19 EXPRESSION_SYSTEM_PLASMID: PGEX-6P-1 KEYWDS ALL-HELICAL DOMAIN, PROTEIN-PEPTIDE COMPLEX, RNA BINDING PROTEIN EXPDTA SOLUTION NMR NUMMDL 30 AUTHOR G.KOZLOV,N.SIDDIQUI,S.COILLET-MATILLON,I.EKIEL,K.GEHRING REVDAT 4 23-FEB-22 1JGN 1 REMARK SEQADV REVDAT 3 24-FEB-09 1JGN 1 VERSN REVDAT 2 01-MAR-05 1JGN 1 JRNL REVDAT 1 24-JUN-03 1JGN 0 JRNL AUTH G.KOZLOV,G.DE CRESCENZO,N.S.LIM,N.SIDDIQUI,D.FANTUS, JRNL AUTH 2 A.KAHVEJIAN,J.F.TREMPE,D.ELIAS,I.EKIEL,N.SONENBERG, JRNL AUTH 3 M.O'CONNOR-MCCOURT,K.GEHRING JRNL TITL STRUCTURAL BASIS OF LIGAND RECOGNITION BY PABC, A HIGHLY JRNL TITL 2 SPECIFIC PEPTIDE-BINDING DOMAIN FOUND IN POLY(A)-BINDING JRNL TITL 3 PROTEIN AND A HECT UBIQUITIN LIGASE JRNL REF EMBO J. V. 23 272 2004 JRNL REFN ISSN 0261-4189 JRNL PMID 14685257 JRNL DOI 10.1038/SJ.EMBOJ.7600048 REMARK 1 REMARK 1 REFERENCE 1 REMARK 1 AUTH G.KOZLOV,J.F.TREMPE,K.KHALEGHPOUR,A.KAHVEJIAN,I.EKIEL, REMARK 1 AUTH 2 K.GEHRING REMARK 1 TITL STRUCTURE AND FUNCTION OF THE C-TERMINAL PABC DOMAIN OF REMARK 1 TITL 2 HUMAN POLY(A)-BINDING PROTEIN REMARK 1 REF PROC.NATL.ACAD.SCI.USA V. 98 4409 2001 REMARK 1 REFN ISSN 0027-8424 REMARK 1 DOI 10.1073/PNAS.071024998 REMARK 2 REMARK 2 RESOLUTION. NOT APPLICABLE. REMARK 3 REMARK 3 REFINEMENT. REMARK 3 PROGRAM : XWINNMR 2.1, CNS 0.9 REMARK 3 AUTHORS : BRUKER SPECTROSPIN (XWINNMR), BRUNGER (CNS) REMARK 3 REMARK 3 OTHER REFINEMENT REMARKS: THE STRUCTURES ARE BASED ON 2058 NON REMARK 3 -REDUNDANT NOE-DERIVED DISTANCE CONSTRAINTS, 106 DIHEDRAL ANGLE REMARK 3 RESTRAINTS, AND 35 HYDROGEN BONDS. REMARK 4 REMARK 4 1JGN COMPLIES WITH FORMAT V. 3.15, 01-DEC-08 REMARK 100 REMARK 100 THIS ENTRY HAS BEEN PROCESSED BY RCSB ON 02-JUL-01. REMARK 100 THE DEPOSITION ID IS D_1000013748. REMARK 210 REMARK 210 EXPERIMENTAL DETAILS REMARK 210 EXPERIMENT TYPE : NMR REMARK 210 TEMPERATURE (KELVIN) : 303 REMARK 210 PH : 6.3 REMARK 210 IONIC STRENGTH : 0.1M NACL REMARK 210 PRESSURE : AMBIENT REMARK 210 SAMPLE CONTENTS : 3MM 15N-LABELED PABC; 4MM REMARK 210 UNLABELED PEPTIDE; 50MM REMARK 210 PHOSPHATE BUFFER; 0.1M NACL; 1MM REMARK 210 NAN3; PH 6.3; 3MM 15N,13C- REMARK 210 LABELED PABC; 4MM UNLABELED REMARK 210 PEPTIDE; 50MM PHOSPHATE BUFFER; REMARK 210 0.1M NACL; 1MM NAN3; PH 6.3; REMARK 210 2.5MM 15N-LABELED PEPTIDE; 3MM REMARK 210 UNLABELED PABC; 50MM PHOSPHATE REMARK 210 BUFFER; 0.1M NACL; 1MM NAN3; PH REMARK 210 6.3; 2MM 15N,13C-LABELED PEPTIDE; REMARK 210 3MM UNLABELED PABC; 50MM REMARK 210 PHOSPHATE BUFFER; 0.1M NACL; 1MM REMARK 210 NAN3; PH 6.3; 3MM UNLABELED PABC; REMARK 210 3MM UNLABELED PEPTIDE; 50MM REMARK 210 PHOSPHATE BUFFER; 0.1M NACL; 1MM REMARK 210 NAN3; PH 6.3; 3MM UNLABELED PABC; REMARK 210 3MM UNLABELED PEPTIDE; 50MM REMARK 210 PHOSPHATE BUFFER; 0.1M NACL; 1MM REMARK 210 NAN3; PH 6.3 REMARK 210 REMARK 210 NMR EXPERIMENTS CONDUCTED : 3D_15N-SEPARATED_NOESY; 3D_13C REMARK 210 -SEPARATED_NOESY; 2D NOESY REMARK 210 SPECTROMETER FIELD STRENGTH : 800 MHZ; 500 MHZ REMARK 210 SPECTROMETER MODEL : UNITYPLUS; DRX REMARK 210 SPECTROMETER MANUFACTURER : VARIAN; BRUKER REMARK 210 REMARK 210 STRUCTURE DETERMINATION. REMARK 210 SOFTWARE USED : GIFA 4.31, XEASY 1.3.13, ARIA REMARK 210 0.9 REMARK 210 METHOD USED : SIMULATED ANNEALING REMARK 210 REMARK 210 CONFORMERS, NUMBER CALCULATED : 200 REMARK 210 CONFORMERS, NUMBER SUBMITTED : 30 REMARK 210 CONFORMERS, SELECTION CRITERIA : STRUCTURES WITH THE LOWEST REMARK 210 ENERGY REMARK 210 REMARK 210 BEST REPRESENTATIVE CONFORMER IN THIS ENSEMBLE : 1 REMARK 210 REMARK 210 REMARK: THE STRUCTURE WAS DETERMINED USING STANDARD TRIPLE REMARK 210 -RESONANCE AND HOMONUCLEAR TECHNIQUES REMARK 215 REMARK 215 NMR STUDY REMARK 215 THE COORDINATES IN THIS ENTRY WERE GENERATED FROM SOLUTION REMARK 215 NMR DATA. PROTEIN DATA BANK CONVENTIONS REQUIRE THAT REMARK 215 CRYST1 AND SCALE RECORDS BE INCLUDED, BUT THE VALUES ON REMARK 215 THESE RECORDS ARE MEANINGLESS. REMARK 300 REMARK 300 BIOMOLECULE: 1 REMARK 300 SEE REMARK 350 FOR THE AUTHOR PROVIDED AND/OR PROGRAM REMARK 300 GENERATED ASSEMBLY INFORMATION FOR THE STRUCTURE IN REMARK 300 THIS ENTRY. THE REMARK MAY ALSO PROVIDE INFORMATION ON REMARK 300 BURIED SURFACE AREA. REMARK 350 REMARK 350 COORDINATES FOR A COMPLETE MULTIMER REPRESENTING THE KNOWN REMARK 350 BIOLOGICALLY SIGNIFICANT OLIGOMERIZATION STATE OF THE REMARK 350 MOLECULE CAN BE GENERATED BY APPLYING BIOMT TRANSFORMATIONS REMARK 350 GIVEN BELOW. BOTH NON-CRYSTALLOGRAPHIC AND REMARK 350 CRYSTALLOGRAPHIC OPERATIONS ARE GIVEN. REMARK 350 REMARK 350 BIOMOLECULE: 1 REMARK 350 AUTHOR DETERMINED BIOLOGICAL UNIT: DIMERIC REMARK 350 APPLY THE FOLLOWING TO CHAINS: A, B REMARK 350 BIOMT1 1 1.000000 0.000000 0.000000 0.00000 REMARK 350 BIOMT2 1 0.000000 1.000000 0.000000 0.00000 REMARK 350 BIOMT3 1 0.000000 0.000000 1.000000 0.00000 REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: CLOSE CONTACTS REMARK 500 REMARK 500 THE FOLLOWING ATOMS ARE IN CLOSE CONTACT. REMARK 500 REMARK 500 ATM1 RES C SSEQI ATM2 RES C SSEQI DISTANCE REMARK 500 REMARK 500 REMARK: NULL REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: TORSION ANGLES REMARK 500 REMARK 500 TORSION ANGLES OUTSIDE THE EXPECTED RAMACHANDRAN REGIONS: REMARK 500 (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN IDENTIFIER; REMARK 500 SSEQ=SEQUENCE NUMBER; I=INSERTION CODE). REMARK 500 REMARK 500 STANDARD TABLE: REMARK 500 FORMAT:(10X,I3,1X,A3,1X,A1,I4,A1,4X,F7.2,3X,F7.2) REMARK 500 REMARK 500 EXPECTED VALUES: GJ KLEYWEGT AND TA JONES (1996). PHI/PSI- REMARK 500 CHOLOGY: RAMACHANDRAN REVISITED. STRUCTURE 4, 1395 - 1400 REMARK 500 REMARK 500 M RES CSSEQI PSI PHI REMARK 500 1 LEU A 3 45.28 -86.18 REMARK 500 1 PRO A 6 -158.73 -68.06 REMARK 500 1 GLN A 22 -80.48 -73.61 REMARK 500 1 MET A 23 -95.24 -69.80 REMARK 500 1 ARG A 27 9.99 -160.06 REMARK 500 1 LEU A 28 -74.88 -59.41 REMARK 500 1 PRO A 37 -28.57 -38.24 REMARK 500 1 THR A 38 -86.54 -78.08 REMARK 500 1 LEU A 39 49.70 -171.46 REMARK 500 1 GLU A 49 21.72 -74.63 REMARK 500 1 ALA A 85 30.69 -84.11 REMARK 500 1 GLN A 86 -78.07 -81.10 REMARK 500 1 LEU B 6 -76.53 -68.94 REMARK 500 1 ALA B 10 93.69 -60.23 REMARK 500 1 PRO B 15 -167.67 -55.82 REMARK 500 2 PRO A 17 -162.08 -68.76 REMARK 500 2 GLN A 22 -77.04 -73.26 REMARK 500 2 MET A 23 -95.91 -68.99 REMARK 500 2 ARG A 27 13.52 -159.96 REMARK 500 2 LEU A 28 -78.85 -57.30 REMARK 500 2 PRO A 37 -32.94 -36.00 REMARK 500 2 THR A 38 -88.38 -78.18 REMARK 500 2 LEU A 39 61.06 -171.31 REMARK 500 2 GLU A 49 20.49 -79.59 REMARK 500 2 PRO A 96 -175.67 -68.52 REMARK 500 2 LEU B 6 -74.78 -68.66 REMARK 500 2 ALA B 10 96.06 -60.96 REMARK 500 2 PRO B 15 -169.86 -55.34 REMARK 500 3 PRO A 6 -159.89 -71.39 REMARK 500 3 PRO A 17 -160.95 -70.31 REMARK 500 3 GLN A 22 -76.75 -72.47 REMARK 500 3 MET A 23 -96.24 -69.16 REMARK 500 3 ARG A 27 13.22 -159.70 REMARK 500 3 LEU A 28 -76.46 -57.32 REMARK 500 3 PRO A 37 -30.39 -37.11 REMARK 500 3 THR A 38 -85.17 -78.28 REMARK 500 3 LEU A 39 51.29 -171.11 REMARK 500 3 ALA A 40 -38.18 -39.83 REMARK 500 3 GLU A 49 22.38 -74.59 REMARK 500 3 ASN B 5 -66.70 -104.32 REMARK 500 3 LEU B 6 -87.44 -64.85 REMARK 500 3 ALA B 10 98.13 -60.57 REMARK 500 3 PRO B 15 -172.83 -55.42 REMARK 500 3 LYS B 18 98.99 -67.19 REMARK 500 4 PRO A 6 -154.95 -70.05 REMARK 500 4 PRO A 17 -157.34 -69.11 REMARK 500 4 GLN A 18 47.44 -74.64 REMARK 500 4 GLN A 22 -79.82 -73.60 REMARK 500 4 MET A 23 -96.09 -69.57 REMARK 500 4 LEU A 24 0.43 -61.04 REMARK 500 REMARK 500 THIS ENTRY HAS 494 RAMACHANDRAN OUTLIERS. REMARK 500 REMARK 500 REMARK: NULL REMARK 900 REMARK 900 RELATED ENTRIES REMARK 900 RELATED ID: 1G9L RELATED DB: PDB REMARK 900 1G9L CONTAINS THE UNCOMPLEXED C-TERMINAL DOMAIN OF HUMAN POLY(A)- REMARK 900 BINDING PROTEIN DBREF 1JGN A 6 98 UNP P11940 PABP1_HUMAN 544 636 DBREF 1JGN B 1 22 UNP Q9BPZ3 PAIP2_HUMAN 106 127 SEQADV 1JGN GLY A 1 UNP P11940 CLONING ARTIFACT SEQADV 1JGN PRO A 2 UNP P11940 CLONING ARTIFACT SEQADV 1JGN LEU A 3 UNP P11940 CLONING ARTIFACT SEQADV 1JGN GLY A 4 UNP P11940 CLONING ARTIFACT SEQADV 1JGN SER A 5 UNP P11940 CLONING ARTIFACT SEQRES 1 A 98 GLY PRO LEU GLY SER PRO LEU THR ALA SER MET LEU ALA SEQRES 2 A 98 SER ALA PRO PRO GLN GLU GLN LYS GLN MET LEU GLY GLU SEQRES 3 A 98 ARG LEU PHE PRO LEU ILE GLN ALA MET HIS PRO THR LEU SEQRES 4 A 98 ALA GLY LYS ILE THR GLY MET LEU LEU GLU ILE ASP ASN SEQRES 5 A 98 SER GLU LEU LEU HIS MET LEU GLU SER PRO GLU SER LEU SEQRES 6 A 98 ARG SER LYS VAL ASP GLU ALA VAL ALA VAL LEU GLN ALA SEQRES 7 A 98 HIS GLN ALA LYS GLU ALA ALA GLN LYS ALA VAL ASN SER SEQRES 8 A 98 ALA THR GLY VAL PRO THR VAL SEQRES 1 B 22 VAL VAL LYS SER ASN LEU ASN PRO ASN ALA LYS GLU PHE SEQRES 2 B 22 VAL PRO GLY VAL LYS TYR GLY ASN ILE HELIX 1 1 LEU A 7 SER A 14 1 8 HELIX 2 2 PRO A 16 GLN A 20 5 5 HELIX 3 3 ARG A 27 MET A 35 1 9 HELIX 4 4 LEU A 39 LEU A 47 1 9 HELIX 5 5 LEU A 48 ILE A 50 5 3 HELIX 6 6 ASP A 51 SER A 61 1 11 HELIX 7 7 SER A 61 GLN A 80 1 20 HELIX 8 8 GLN A 80 ALA A 85 1 6 CISPEP 1 SER A 5 PRO A 6 3 -1.64 CISPEP 2 PRO A 16 PRO A 17 5 3.22 CISPEP 3 SER A 5 PRO A 6 9 -0.99 CISPEP 4 PRO A 16 PRO A 17 10 2.22 CISPEP 5 GLY A 1 PRO A 2 11 0.34 CISPEP 6 VAL A 95 PRO A 96 12 0.78 CISPEP 7 PRO A 16 PRO A 17 13 3.90 CISPEP 8 SER A 5 PRO A 6 16 -1.79 CISPEP 9 GLY A 1 PRO A 2 18 0.38 CISPEP 10 SER A 5 PRO A 6 20 -0.04 CISPEP 11 GLY A 1 PRO A 2 24 0.49 CISPEP 12 VAL A 95 PRO A 96 24 0.77 CISPEP 13 GLY A 1 PRO A 2 25 0.45 CISPEP 14 HIS A 36 PRO A 37 28 4.08 CISPEP 15 HIS A 36 PRO A 37 29 5.16 CISPEP 16 GLY A 1 PRO A 2 30 0.18 CRYST1 1 ORIGX1 1.000000 0.000000 0.000000 0.00000 ORIGX2 0.000000 1.000000 0.000000 0.00000 ORIGX3 0.000000 0.000000 1.000000 0.00000 SCALE1 1.000000 0.000000 0.000000 0.00000 SCALE2 0.000000 1.000000 0.000000 0.00000 SCALE3 0.000000 0.000000 1.000000 0.00000 MODEL 1 MODEL 2 MODEL 3 MODEL 4 MODEL 5 MODEL 6 MODEL 7 MODEL 8 MODEL 9 MODEL 10 MODEL 11 MODEL 12 MODEL 13 MODEL 14 MODEL 15 MODEL 16 MODEL 17 MODEL 18 MODEL 19 MODEL 20 MODEL 21 MODEL 22 MODEL 23 MODEL 24 MODEL 25 MODEL 26 MODEL 27 MODEL 28 MODEL 29 MODEL 30